In accordance with MIF and CXCL8, the clinical significance of CCL4 was not consistent, even opposite, in different cancers, suggesting that the biological functions of these cytokines in tumorigenesis and therapy response are complicated and labile and may be tumor type-specific. This evidence concerns the gene CCL4 and cancer.